Both schemes are connected by the Cypriot company Dimicandum Invest Holding LTD and are linked to the Presidential Affairs Department of Belarus.

Purchasing only three types of medications, which we will discuss in the investigation, in Russian pharmacies would have cost the budget $2 million less than buying wholesale from a Belarusian supplier.